Final programme - Posters sessions

S02P Structure and dynamics of cholinesterases and OP hydrolases
S02P-1       3D structure of natural tetrameric form of human butyrylcholinesterase obtained by Cryo-electron microscopy
Konstanin M. Boyko
S02P-2 Butyrylcholinesterase-proteins interactions in human blood serum
Jacek Jasiecki
S02P-3 Dimerization interface of cholinesterases: analysis of crystal structures, free energy molecular dynamics calculations,and in silico alanine screening
Novichkova D. A.
Interaction of cholinesterases with substrates, inhibitors and reactivators
S03P-1 4-aminoquinolines as reversible inhibitors of human cholinesterase activity
Anita Bosak
S03P-2 Synthesis of Nerve Agents’ surrogates from Dialkyl Alkylphosphonates for Antidote Screening and Toxicological Studies
Samir F. de A. Cavalcante
S03P-3 Biological evaluation of cysteine targeted insecticides
Hrabinova M., Schmidt M.
S03P-4 An alternative substrate for human erythrocyte Acetylcholinesterase activity detection
Sheemona Chowdhary
S03P-5 Acetylcholinesterase reactivators based on oxime-functionalized biodegradable ionic liquids
Yevgen Karpichev
S03P-6 In silico screening of novel BChE-reactivators
Tomas Kucera
S03P-7 Phenyltetrahydroisoquinoline-based triazole compounds are high-affinity potential reactivators of nerve agent-inhibited human acetylcholinesterase
Nikolina Maček Hrvat
S03P-8 In silico and In vitro evaluation of two novel oximes K456 and K733 against paraoxon inhibited human acetylcholinesterase and butyrylcholinesterase
Syed M Nurulain
S03P-9 Facile synthesis of cysteine-acetylcholinesterase targeted insecticides
Miroslav Psotka
S03P-10 Inhibition of human acetylcholinesterase and butyrylcholinesterase by methylene violet 3RAX
Seda Onder
S03P-11 Molecular modeling studies on the interactions of aflatoxin B1 and its metabolites with pheripheral and catalytic anionic sites of human acetylcholinesterase
Joyce S. F. D. de Almeida
S03P-12 Chlorinated pyridinium oximes are potent reactivators of acetylcholinesterase inhibited by nerve agents
Tamara Zorbaz
S03P-13 Expi 293 cells expressing an endogenous wild-type butyrylcholinesterase, and a variety of esterases that self-reactivates after phosphylation by all types of organophosphorus agents
Irina Zueva
S03P-14          Bistable dynamic behavior of endogenous butyrylcholinesterase expressed in Expi293 cells
Irina Zueva
S04P           Reactivators of AChE, OP inhibitors - mechanism of toxicity, detection and analytical methods, diagnosis of exposure, detoxification and therapy;
counter-terrorism strategies
S04P-1 Reactivating efficacy of oximes K203 and K027 against a direct acetylcholinesterase inhibitor in rat diaphragm: dose-response modeling
Evica Antonijevic
S04P-2 Inhibition of cholinesterases following percutaneous intoxication with V agents in rats
Jiri Bajgar
S04P-3 Near attack conformation approach for molecular modeling studies upon the prophylactic agent 7-methoxytacrine-4-pyridinealdoxime hybrid compared with other reactivators of VX-inhibited HssAChE
Tanos Celmar Costa França
S04P-4 Design, synthesis and in vitro evaluation of a promising new class of bifunctional uncharged hybrid reactivators for nerve agent-inhibited human acetylcholinesterase
José Dias
S04P-5 The early tissue alteration induced by different oximes in rats
Vesna Jaćević
S04P-6 Cytotoxicity stody of oxime@CB7 complexes for central nervous system penetration of quaternary acetylcholinesterase reactivators
Petr Jost
S04P-7 Brain Exposure of bis-Pyridinium Oxime KR-26256
Young-Sik Jung
S04P-8 Analysis of bis-pyridinium mono-aldoximes in serum and organs using a high-throughput high performance liquid chromatography approach
Gellert Karvaly
S04P-9 A comparison of the reactivating and therapeutic efficacy of a novel bispyridinium oxime K870 with commonly used pralidoxime and the oxime HI-6 in sarin-poisoned rats and mice
Jiri Kassa
S04P-10 The monoquarternary reactivators for the treatment of organophoshorous intoxication
Korabecny J.
S04P-11 Decontamination of warfare agent
Jan Marek
S04P-12 In vitro characterization of the standard acetylcholinesterase reactivators
Muckova L., Hepnarova V.
S04P-13 Uncharged Reactivators of Cholinesterases Inhibited by Organophosphorus Nerve Agents
N. Probst
S04P-14 In vitro determination of oxidative stress induced by oxime reactivators using chromatographic methods
Váňova N.
S04P-15 In vitro evaluation of quinuclidinium oximes as reactivators of human cholinesterases inhibited by organophosphorus compounds
Antonio Zandona
S05P Enzymes and proteins other than ChEs interacting with OP
S05P-1 Determination of BChE Activity by Mass Spectrometric Analysis of Its Adduct with Russian Vx
Murashko E.A.
S05P-2 An in-vitro induction of Paraoxonase 3 activity in Hepatocytes by Resveratrol
Kumari Priyanka
S06P Stoichiometric bioscavanger, biotechnology and therapeutical aspects
S06P-1 Smart & Innovative Tools for Cholinesterases Related Applications
Emilie David
S06P-2 In Vitro Evaluation of Standard Acetylcholinesterase Reactivators as Reactivators of Human Plasma Butyrylcholinesterase
Lucie Junova
S09P Biological functions, development and non-cholinergic function
of cholinesterases
S09P-1 Butyrylcholinesterase and its variants (rs3495 & rs1803274) association with Major Depressive Disorder
Sliha Awan
S09P-2 Alkaloids derived from traditional Chinese medicine are inhibitors for inflammation and acetylcholinesterase
Xiang P. Kong
S09P-3 Acetylcholinesterase regulates inflammatory responses in cultured macrophages: a player in cholinergic anti-inflammatory pathway
Etta Y. L. Liu
S09P-4 Genistein, a phytoestrogen in soybean, induces the expression of acetylcholinesterase via G protein-coupled receptor 30 in PC12 cells
Etta Y. L. Liu
S09P-5 Status of Cholinesterases in Heroin, Hashish (Cannabis) and Polydrug Addicts
Syed M Nurulain
S09P-6 Indirect effects of dioxin on neuronal AChE expression via astrocytes
Rui Sha
S09P-7 Non-neuronal cholinergic system in rat aorta
Szmicseková K.
S09P-8 Microphthalmia-associated transcription factor regulates acetylcholinesterase expression during melanogenesis of B16F10 cells: a cholinergic regulator in pigmentation
Qiyun Wu
S10P Alzheimer's disease and diseases related to cholinesterases
S10P-1 Dual binding site inhibitors of acetylcholinesterase as therapeutic treatments for Alzheimer’s disease: any need for an update?
K. Petrov
S10P-2 Detection of Alzheimer’s drug candidate by Surface-Enhanced Raman Spectroscopy
Jan Proska
S11P Multi-target-directed ligands in Alzheimer's disease primarily targeting cholinesterases
S11P-1 Butyrylcholinesterase inhibitors grafted with antioxidant and neuroprotective activities: novel multifunctional ligands for Alzheimer’s disease
Damijan Knez
S11P-2 7-MEOTA-donepezil hybrids: Potential cholinesterase inhibitors for the treatment of Alzheimer’s disease
Katarina Spilovska